Item Type | Name |
Concept
|
Urinary Bladder Neoplasms
|
Academic Article
|
Eosinophilic cystitis presenting as a recurrent symptomatic bladder mass following intravesical mitomycin C therapy.
|
Academic Article
|
Analysis of early complications after radical cystectomy: results of a collaborative care pathway.
|
Academic Article
|
Decreasing blood loss in patients treated with radical cystectomy: a prospective randomizes trial using a new stapling device.
|
Academic Article
|
Health related quality of life in patients treated with radical cystectomy and urinary diversion for urothelial carcinoma of the bladder: development and validation of a new disease specific questionnaire.
|
Academic Article
|
Benefit of radical cystectomy in the elderly patient with significant co-morbidities.
|
Academic Article
|
The surgical management of muscle invasive bladder cancer: a contemporary review.
|
Academic Article
|
Urothelial carcinoma of the bladder metastatic to bone marrow presenting as isolated thrombocytopenia.
|
Academic Article
|
Risk factors for urothelial carcinoma of the prostate in patients undergoing radical cystoprostatectomy for bladder cancer.
|
Academic Article
|
Outcomes of patients undergoing radical cystoprostatectomy for bladder cancer with prostatic involvement on final pathology.
|
Academic Article
|
Determining factors for hospital discharge status after radical cystectomy in a large contemporary cohort.
|
Academic Article
|
Effect of preoperative nutritional deficiency on mortality after radical cystectomy for bladder cancer.
|
Academic Article
|
The relationship between perioperative blood transfusion and overall mortality in patients undergoing radical cystectomy for bladder cancer.
|
Academic Article
|
Lymph node yield at radical cystectomy predicts mortality in node-negative and not node-positive patients.
|
Academic Article
|
Incidence and predictors of understaging in patients with clinical T1 urothelial carcinoma undergoing radical cystectomy.
|
Academic Article
|
Blood loss associated with radical cystectomy: a prospective, randomized study comparing Impact LigaSure vs. stapling device.
|
Academic Article
|
Trends in the use of perioperative chemotherapy for localized and locally advanced muscle-invasive bladder cancer: a sign of changing tides.
|
Academic Article
|
Impact of complications and hospital-free days on health related quality of life 1 year after radical cystectomy.
|
Academic Article
|
Use of intravesical valrubicin in clinical practice for treatment of nonmuscle-invasive bladder cancer, including carcinoma in situ of the bladder.
|
Academic Article
|
Radical Cystectomy-The Waiting is the Hardest Part…or is it?
|
Academic Article
|
Oncologic Outcomes after Anterior Exenteration for Muscle Invasive Bladder Cancer in Women.
|
Academic Article
|
Improving the quality of operative reports for transurethral resection of bladder tumor surgery in resident education.
|
Academic Article
|
Concomitant CIS on TURBT does not impact oncological outcomes in patients treated with neoadjuvant or induction chemotherapy followed by radical cystectomy.
|
Academic Article
|
Impact of sex on response to neoadjuvant chemotherapy in patients with bladder cancer.
|
Academic Article
|
Management of stage T1 superficial bladder cancer with intravesical bacillus Calmette-Guerin therapy.
|
Academic Article
|
Radical cystectomy in the octogenarian.
|
Academic Article
|
Pathological findings of gynecologic organs obtained at female radical cystectomy.
|
Academic Article
|
Health related quality of life assessment after radical cystectomy: comparison of ileal conduit with continent orthotopic neobladder.
|
Academic Article
|
Incidence and location of prostate and urothelial carcinoma in prostates from cystoprostatectomies: implications for possible apical sparing surgery.
|
Academic Article
|
Outcomes in patients with pathological carcinoma in situ only disease at radical cystectomy.
|
Academic Article
|
Urethral recurrence in patients following orthotopic urinary diversion.
|
Academic Article
|
Patterns of initial transitional cell recurrence in patients after cystectomy.
|
Academic Article
|
Association of procedure volume with radical cystectomy outcomes in a nationwide database.
|
Academic Article
|
National practice patterns for immediate postoperative instillation of chemotherapy in nonmuscle invasive bladder cancer.
|
Academic Article
|
Surgical and chemotherapeutic management of regional lymph nodes in bladder cancer.
|
Academic Article
|
ICUD-EAU International Consultation on Bladder Cancer 2012: Radical cystectomy and bladder preservation for muscle-invasive urothelial carcinoma of the bladder.
|
Academic Article
|
Screening for bladder cancer: rationale, limitations, whom to target, and perspectives.
|
Academic Article
|
Korean version of the functional assessment of cancer therapy (FACT)-vanderbilt cystectomy index (VCI): translation and linguistic.
|
Academic Article
|
Loss of FOXA1 Drives Sexually Dimorphic Changes in Urothelial Differentiation and Is an Independent Predictor of Poor Prognosis in Bladder Cancer.
|
Academic Article
|
Minimally Invasive Versus Open Approach for Cystectomy: Trends in the Utilization and Demographic or Clinical Predictors Using the National Cancer Database.
|
Academic Article
|
Robot-assisted radical cystectomy versus open radical cystectomy in patients with bladder cancer (RAZOR): an open-label, randomised, phase 3, non-inferiority trial.
|
Academic Article
|
Risk of Ovarian Malignancy in Patients Undergoing Radical Cystectomy for Bladder Cancer.
|
Academic Article
|
The prognostic value of the neutrophil-to-lymphocyte ratio in patients with muscle-invasive bladder cancer treated with neoadjuvant chemotherapy and radical cystectomy.
|
Academic Article
|
Comparative effectiveness of neoadjuvant chemotherapy in bladder and upper urinary tract urothelial carcinoma.
|
Academic Article
|
Upper tract tumors in patients with primary bladder cancer followed for 15 years.
|
Academic Article
|
Clinical under staging of high risk nonmuscle invasive urothelial carcinoma treated with radical cystectomy.
|
Academic Article
|
Preservation of the anterior vaginal wall during female radical cystectomy with orthotopic urinary diversion: technique and results.
|
Academic Article
|
Radical cystectomy for bladder cancer: the case for early intervention.
|
Academic Article
|
Non-muscle-invasive bladder cancer: the role of radical cystectomy.
|
Academic Article
|
Comparison of american joint committee on cancer pathological stage T2a versus T2b urothelial carcinoma: analysis of patient outcomes in organ confined bladder cancer.
|
Academic Article
|
Bacillus calmette-guérin failures and beyond: contemporary management of non-muscle-invasive bladder cancer.
|
Academic Article
|
Comparison of American Joint Committee on Cancer pathologic stage T3a versus T3b urothelial carcinoma: analysis of patient outcomes.
|
Academic Article
|
Early and late perioperative outcomes following radical cystectomy: 90-day readmissions, morbidity and mortality in a contemporary series.
|
Academic Article
|
Trends in the utilization of neoadjuvant chemotherapy in muscle-invasive bladder cancer: results from the National Cancer Database.
|
Academic Article
|
The Impact of Blue Light Cystoscopy with Hexaminolevulinate (HAL) on Progression of Bladder Cancer - A New Analysis.
|
Academic Article
|
Bladder Cancer Recovery Pathways: A Systematic Review.
|
Academic Article
|
Robotic Cystectomy with Intracorporeal Urinary Diversion: Review of Current Techniques and Outcomes.
|
Academic Article
|
Neoadjuvant chemotherapy plus radical cystectomy versus radical cystectomy alone in clinical T2 bladder cancer without hydronephrosis.
|
Academic Article
|
Causes of increased hospital stay after radical cystectomy in a clinical pathway setting.
|
Academic Article
|
Routine postoperative intensive care monitoring is not necessary after radical cystectomy.
|
Academic Article
|
Carcinoma in situ and tumor multifocality predict the risk of prostatic urethral involvement at radical cystectomy in men with transitional cell carcinoma of the bladder.
|
Academic Article
|
Causes of increased length of stay following radical cystectomy.
|
Academic Article
|
Orthotopic neobladder following radical cystectomy in patients with high perioperative risk and co-morbid medical conditions.
|
Academic Article
|
Complications of radical cystectomy for nonmuscle invasive disease: comparison with muscle invasive disease.
|
Academic Article
|
Delaying radical cystectomy for muscle invasive bladder cancer results in worse pathological stage.
|
Academic Article
|
A comparison of hexaminolevulinate fluorescence cystoscopy and white light cystoscopy for the detection of carcinoma in situ in patients with bladder cancer: a phase III, multicenter study.
|
Academic Article
|
Urinary diversion trends at a high volume, single American tertiary care center.
|
Academic Article
|
Preoperative hydronephrosis predicts extravesical and node positive disease in patients undergoing cystectomy for bladder cancer.
|
Academic Article
|
Predicting the probability of 90-day survival of elderly patients with bladder cancer treated with radical cystectomy.
|
Academic Article
|
Loss of the urothelial differentiation marker FOXA1 is associated with high grade, late stage bladder cancer and increased tumor proliferation.
|
Academic Article
|
Voiding function in women with orthotopic neobladder urinary diversion.
|
Academic Article
|
Psychometric characteristics of a condition-specific, health-related quality-of-life survey: the FACT-Vanderbilt Cystectomy Index.
|
Academic Article
|
Volume outcomes of cystectomy--is it the surgeon or the setting?
|
Academic Article
|
Challenges in the pathology of non-muscle-invasive bladder cancer: a dialogue between the urologic surgeon and the pathologist.
|
Academic Article
|
Locoregional small cell carcinoma of the bladder: clinical characteristics and treatment patterns.
|
Academic Article
|
Racial variation in the quality of surgical care for bladder cancer.
|
Academic Article
|
Hexaminolevulinate blue-light cystoscopy in non-muscle-invasive bladder cancer: review of the clinical evidence and consensus statement on appropriate use in the USA.
|
Academic Article
|
Multicenter assessment of neoadjuvant chemotherapy for muscle-invasive bladder cancer.
|
Academic Article
|
A 10-Item Checklist Improves Reporting of Critical Procedural Elements during Transurethral Resection of Bladder Tumor.
|
Academic Article
|
Short term complications from transurethral resection of bladder tumor.
|
Academic Article
|
Epidemiology, prevention, screening, diagnosis, and evaluation: update of the ICUD-SIU joint consultation on bladder cancer.
|
Academic Article
|
Optimal Trial Design for Studying Urinary Markers in Bladder Cancer: A Collaborative Review.
|
Academic Article
|
Predictors of Recurrence, and Progression-Free and Overall Survival following Open versus Robotic Radical Cystectomy: Analysis from the RAZOR Trial with a 3-Year Followup.
|
Academic Article
|
Nomogram Predicting Bladder Cancer-specific Mortality After Neoadjuvant Chemotherapy and Radical Cystectomy for Muscle-invasive Bladder Cancer: Results of an International Consortium.
|
Academic Article
|
Intravesical nadofaragene firadenovec gene therapy for BCG-unresponsive non-muscle-invasive bladder cancer: a single-arm, open-label, repeat-dose clinical trial.
|
Academic Article
|
The treated natural history of high risk superficial bladder cancer: 15-year outcome.
|
Academic Article
|
Identifying the Optimal Number of Neoadjuvant Chemotherapy Cycles in Patients with Muscle Invasive Bladder Cancer.
|
Academic Article
|
Association of age with response to preoperative chemotherapy in patients with muscle-invasive bladder cancer.
|
Academic Article
|
Antiadenovirus Antibodies Predict Response Durability to Nadofaragene Firadenovec Therapy in BCG-unresponsive Non-muscle-invasive Bladder Cancer: Secondary Analysis of a Phase 3 Clinical Trial.
|
Academic Article
|
Corrigendum to "Nomogram Predicting Bladder Cancer-specific Mortality After Neoadjuvant Chemotherapy and Radical Cystectomy for Muscle-invasive Bladder Cancer: Results of an International Consortium" [Eur Urol Focus 2021;7:1347-54].
|
Academic Article
|
Intermediate-risk Non-muscle-invasive Bladder Cancer: Updated Consensus Definition and Management Recommendations from the International Bladder Cancer Group.
|
Academic Article
|
Multicenter evaluation of neoadjuvant and induction gemcitabine-carboplatin versus gemcitabine-cisplatin followed by radical cystectomy for muscle-invasive bladder cancer.
|
Academic Article
|
Impact of Maximal Transurethral Resection on Pathological Outcomes at Cystectomy in a Large, Multi-institutional Cohort.
|
Academic Article
|
The Influence of Access Related Factors on Adherence to Clinical Practice Guidelines for Muscle Invasive Bladder Cancer.
|
Academic Article
|
Advances in diagnosis and treatment of bladder cancer.
|